BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 310 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $605,000 | +3.8% | 4,000 | 0.0% | 0.26% | +13.3% |
| Q2 2022 | $583,000 | +23.0% | 4,000 | 0.0% | 0.23% | +49.4% |
| Q1 2022 | $474,000 | -14.0% | 4,000 | 0.0% | 0.16% | -7.1% |
| Q4 2021 | $551,000 | -0.9% | 4,000 | 0.0% | 0.17% | -8.2% |
| Q3 2021 | $556,000 | +43.3% | 4,000 | 0.0% | 0.18% | +45.2% |
| Q2 2021 | $388,000 | +42.1% | 4,000 | 0.0% | 0.13% | +32.6% |
| Q1 2021 | $273,000 | -20.4% | 4,000 | 0.0% | 0.10% | -25.2% |
| Q4 2020 | $343,000 | +31.9% | 4,000 | 0.0% | 0.13% | +16.5% |
| Q3 2020 | $260,000 | -11.0% | 4,000 | 0.0% | 0.11% | -18.0% |
| Q2 2020 | $292,000 | +33.9% | 4,000 | 0.0% | 0.13% | +47.8% |
| Q4 2019 | $218,000 | – | 4,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $108,659,000 | 54.35% |
| Knoll Capital Management, LLC | 749,815 | $38,593,000 | 29.33% |
| VHCP Management II, LLC | 1,138,075 | $58,577,000 | 17.14% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,021,392 | $52,571,000 | 11.19% |
| Aisling Capital Management LP | 274,513 | $14,129,000 | 10.76% |
| Foresite Capital Management IV, LLC | 518,560 | $26,690,000 | 9.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 844,266 | $43,454,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 206,000 | $10,603,000 | 5.04% |
| ARS Investment Partners, LLC | 464,127 | $23,889,000 | 4.32% |
| Cormorant Asset Management, LP | 1,100,000 | $56,617,000 | 3.83% |